Opuntia genus in Human Health: A Comprehensive Summary on Its Pharmacological, Therapeutic and Preventive Properties. Part 1
Abstract
:1. Introduction
2. Opuntia genus in Mexico
3. Nutritional Value, Bioactive Compounds and Main Mechanisms of Action Involved
4. Pharmacological, Therapeutic and Preventive Properties
4.1. Effects on Atherosclerotic Cardiovascular Diseases
Type of Study | Objective and Characteristics | Results and Conclusion | Ref. |
---|---|---|---|
Hypolipidemic and hypocholesterolemic effect | |||
In vivo | The objective was to evaluate the effect of pectin (extracted from CLD) in the metabolism of Cho and bile acids in male Wistar rats. The animals were fed during 4 weeks with a pectin supplemented diet (7 g/100 g) where Cho regulatory enzymes (HMG-CoA reductase and Cho7AH), concentrations of circulating and hepatic lipids and the excretion of fecal bile acids were measured. | After this period, lower concentrations of Cho were found in serum and liver, as well as a significant excretion of fecal bile acids and a greater activity of Cho7AH and HMG-CoA reductase. It was concluded that pectin favors the decrease of hepatic cholesterol and its serum concentrations. | [23] |
Clinical study | Considering that the PPFs is a traditional food of the American indigenous population, the effect of its pulp was evaluated in 15 patients of both genders who suffered from isolated heterozygous familial hypercholesterolemia (FH). | After a daily consumption of 250 g of pulp for four weeks, tCho and LDL-Cho had diminished in all patients, being more significant in men. Likewise, when analyzing the oxidative damage using the biomarker 8-epi-PGF (2 alpha), a decrease in plasma, serum, and urine was evidenced. The results suggest that the consumption of PPFs can reduce oxidative lesions and benefit the cardiovascular system. | [24] |
Clinical study | In this pilot study the aim was to evaluate the effects of PPFs on lipid metabolism. A group of 24 men with FH (without diabetes and obesity) consumed its pulp (250 g/day) for eight weeks. | After this period, a significant reduction of tCho (12%), LDL-Cho (15%), TG (12%) and apolipoprotein B (9%) was observed. The conclusion was that PPFs may show a hypocholesterolemic action due to the content of soluble fiber (such as pectin). | [25] |
In vivo | A glycoprotein (GOFI) was isolated from O. ficus-indica var. Saboten to determine its ability to reduce the plasma lipid level through scavenging of intracellular radicals in Triton WR-1339-induced mice. GOFI was orally administered to the animals (50 mg/kg) for two weeks. | The results showed that GOFI reduced the plasma levels of triglycerides (TG), total concentration of cholesterol (tCho) and Low-density lipoproteins (LDL) induced by Triton WR-1339. In addition, a decrease in the level of thiobarbituric acid-reactive substances (TBARS) and an increase in the enzymatic activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were observed. The hypolipidemic effect is probably related to the antioxidant capacity of GOFI. | [26] |
In vivo | The purpose of this study was to evaluate the hypolipidemic effect of a methanol extract (MeOH) from O. joconostle (OJ) seeds in mice fed with a hypercholesterolemic diet. | It was initially found that the oral lethal dose 50 (LD₅₀) was greater than 5000 mg/kg. The supplementation of the extract (doses of 1, 2 and 5 g/kg) significantly decreased the concentrations of TG, tCho and LDL-cholesterol (LDL-Cho). The hypolipidemic effect of MeOH was probably due to the phenolic composition of the seeds and the dose administered. | [27] |
Clinical study | Considering that NeOpuntia is a nutritional supplement obtained from dehydrated leaves of OFI, the purpose of this monocentric study, randomized, and placebo-controlled was to analyze its effect on blood lipid parameters of 59 women. During 6 weeks, the individuals consumed balanced diets with controlled lipid intakes plus NeOpuntia capsules (1.6 g dose per meal) and TG, LDL-Cho, and HDL-Cho (High-density lipoprotein cholesterol) levels were measured. | Most of the women showed an increase in HDL-Cho levels and a decrease in blood levels of TG and LDL-Cho. The results suggest that NeOpuntia may reduce cardiovascular risks. | [28] |
Clinical study | After subjecting 10 patients with FH to a dietary treatment with PPFs for 6 weeks, the hypolipidemic potential of this fruit was evaluated by the uptake of autologous (123) I-radiolabeled LDL. | The results showed a relevant increase in the hepatic uptake of LDL and consequently, lower levels of tCho and LDL-Cho in the circulating blood. These findings suggest that the beneficial effect is related to a positive regulation of the receptor [(123) I-LDL]. | [30] |
In vivo | Stem intake of O. humifusa (OHF) was examined on the regulation of lipid concentrations in Sprague-Dawley rats with streptozotocin (STZ) injection-induced diabetes mellitus (DM). The animals were treated orally with two doses of OHF (150 and 250 mg/kg per day) for seven weeks. | Both treatments favored a level lowering of TG, tCho and LDL-Cho. Furthermore, the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations were significantly reduced compared to the DM control group. These results suggest that OHF is potentially hypolipidemic. | [31] |
In vivo | The capacity of ODP-Ia (main component of O. dillenii Haw (OdHw) polysaccharides) on lipid concentration in hyperlipidemic rats induced by high-fat emulsion was analyzed. | After the oral administration of ODP-Ia, serum lipid levels and liver concentrations of tCho and TG significantly decreased. The same treatment increased the activity of cholesterol acyltransferase and SOD (serum and hepatic) and inhibited the action of HMG-CoA reductase and the content of malondialdehyde (hepatic and serum). In addition, by means of a histopathological analysis, the inhibition of the infiltration of inflammatory cells was observed. Together, these results suggest that ODP-Ia is a natural product that can be used in the treatment of hyperlipidemic diseases and that their mechanisms of action are related to the antioxidant potential and the modulation of the enzymes involved in the metabolism of Cho. | [32] |
In vitro | In this test, the effect of piscidic acid and some derivatives of isorhamnetin (Isorhamnetin glucosyl-rhamnosyl-rhamnoside, isorhamnetin-glucosyl-rhamnosyl-pentoside, isorhamnetin-3-O-glucosyl-pentoside, Isorhamnetin-3-O-rutinoside) was evaluated on the absorption of Cho in a monolayer of Caco-2 cells. | The results indicated an approximate 38% reduction in Cho permeation, while for phenolic compounds it was 6% (isorhamnetin) and 9% (piscidic acid). It was also observed that the mixture of both phytochemicals showed an IC50 of 20.3 μg/mL (inhibition of the HMG-CoA enzyme), while for the piscidic acid it was 149.6 μg/mL. This value was slightly exceeded by isorhamnetin derivatives. The data suggest considering OFI as a promising plant for the development of new pharmaceuticals with hypocholesterolemic potential because its bioactive compounds could bind to the active site of the HMG-CoA enzyme. | [33] |
Systematic review | Despite the concise benefits of Opuntia spp. in ASCVD, there is still some confusion about the lipid-lowering effect between its CLD and PPFs. Due to that confusion a systematic review of the characteristic was carried out (from February to September 2019) in the main electronic databases, considering both plant parts and using keywords such as tCho, LDL-Cho, HDL-Cho and TG. Eleven articles (6 from PPFs, 4 from CLD and 1 from commercial products) met the established criteria. | In summary, the consumption of PPFs is associated with significant reductions in tCho, LDL-Cho and TG; while in CLD the lipid-lowering effect is less and there is a datum on a significant increase in HDL-Cho. Possibly, the discrepancies in this effect are caused by the different chemical compositions between CLD and PPFs. Therefore, it would be more feasible to identify the components of Opuntia spp. with greater precision in future studies. | [34] |
In vivo | The content of the total phenolic content and the antioxidant and antihyperlipidemic activities of the seed oil of O. dillenii Haw (OdHw) were evaluated. Using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay and the Folin-Ciocalteu method, the antioxidant activity and phenolic content were tested. The other property was evaluated in albino mice fed a high-fat diet plus OdHw (2 mL/kg). | The oil showed a high phenolic content and DPPH scavenging activity. It also presented a significant antihyperlipidemic effect by improving the lipid profile of the animals; which suggests that this property is related to the antioxidant activity and the phenolic content of the plant’s seeds. | [35] |
Antiatherogenic effect | |||
In vitro | As is known, atherosclerosis is a chronic process where macrophages stimulate inflammatory cascades that promote endothelial dysfunction and allow the constitutive form of ICAM-1 to be expressed. Therefore, the ability of two betalains (betanin and Ind) from PPFs to protect the endothelium from cytokine-induced oxidative alteration by inhibiting ICAM-1 was evaluated. Human umbilical vein endothelial cells (HUVECs) were stimulated with TNF-α and flow cytometry measurements were subsequently performed by incubation with anti-human-ICAM-1. | The results showed that both pigments were able to slightly inhibit ICAM-1 expression up to a micromolar concentration. The antioxidant evaluation of these phytochemicals opens the possibility to develop pharmacological studies that are related to other pathologies characterized by endothelial dysfunction such as atherothrombosis, low limb ischemia, and stroke. | [22] |
In vitro | The purpose of the study was to investigate the protection of different Opuntia CLDs (OS, OH, OA, OM, OFI) in powder form against LDL oxidation caused by vascular endothelial cells and the toxicity of 4-hydroxynonenal under normal conditions (Apc +/+) and in preneoplastic immortalized epithelial colon cells (Apc min/+). | All powders showed a significant inhibition of the oxidation induced by incubation with murine endothelial cells and the foam cell formation of RAW 264.7 murine macrophages. Furthermore, they reduced murine endothelial cell cytotoxicity and colon cancer development in the in vitro model. The conclusion was that the therapeutic potential of cladodes is related to their antioxidant capacity and their content of phenolic acid and flavonoids. | [29] |
In vitro | Since macrophage apoptosis induced by 7-ketocholesterol (7-KC) is a key event in the development of human atheromas, the study of the effect of Ind on 7-KC-induced apoptosis of human monocyte/macrophage THP-1 cells was considered. The proapoptotic potential of 7-KC was evaluated by cell cycle arrest, phosphatidylserine exposure in the plasma membrane, variation of nuclear morphology, and activation of the antagonist Bcl-2 (B-cell lymphoma 2) of cell death. | During the first 24 h, elevated ROS levels were observed, preceding the overexpression of NADPH oxidase-4 (NOX-4) and the elevation of cytosolic Ca²⁺; confirming the 7-KC-dependent activation of the redox-sensitive NF-κB; while the co-incubation of Ind (2.5 μm) prevented such pro-apoptotic events. This pigment of PPFs might protect against atherogenic toxicity of 7-KC by inhibiting overexpression of NOX-4, inhibiting the activation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF -κB), the maintenance of cellular redox balance and Ca²⁺ homeostasis. | [36] |
In vivo | The purpose of the study was to determine whether CLDs of OS and OFI could prevent the development of atherosclerosis in ApoE(-)KO mice. Likewise, using both Opuntia species, the concentration of ROS, the kinetics of LDL oxidation by murine CRL2181 endothelial cells, and the capacity of the inflammatory process to induce the adhesion of monocytes in the activated endothelium and the formation of foam cells were determined. | The evidence showed that OS and OFI had significantly reduced the extracellular generation of superoxide anion, the oxidation of LDL and its subsequent signaling cascade (including the expression of ICAM-1 and NFκB). A reduction in atherosclerotic lesions and 4-hy-droxynonenal adducts in the vascular wall of mice was also observed. Therefore, it is suggested that both Opuntia species (wild and domesticated) show antioxidant, anti-inflammatory, and anti-atherogenic properties. | [37] |
Clinical study | Considering that the antioxidant properties of OFI have been associated with a reduction in body fat, the effects of a dietary supplementation of a 3% OFI extract (500 g per week) was analyzed in 49 individuals (13 men and 36 women). The complete profile of the LDL subclass was evaluated by gel electrophoresis for one month. | The study showed in a percentage increase of LDL-1 and a concomitant reduction in LDL-2; which suggest that OFI extract may have beneficial effects on LDL particle size making them less atherogenic. | [38] |
4.2. Effects on Diabetes and Obesity
4.3. Hepatoprotective Effect
4.4. Effects on Human Infertility
4.5. Chemopreventive and Antigenotoxic Effects
Type of Study | Objective and Characteristics | Results and Conclusion | Ref. |
---|---|---|---|
In vitro In vivo | The purpose of the study was to evaluate the antioxidant capacity of three varieties of PPF juice [red-purple (PPRP), white-green (PPWG) and yellow-orange (PPYO)] in five different concentrations (100, 250, 500, 750 and 1000 mg/mL) by means of the DPPH method and selecting the variety with the highest antioxidant capacity to determine its anticlastogenic potential against MMS. | NIH mice were administered orally with PPRP and subsequently MMS was injected; which resulted in that PPRP was not a genotoxic agent, on the contrary, the reduction of MN frequency was proportional to the dose. | [4] |
In vivo | The purpose of the study was to evaluate the antigenotoxic effect of CCE against AFB1-induced damage in Balb/C mice. Animals were pretreated intraperitoneally with SCC (50 mg/kg body weight) for 2 weeks. | The results indicated that AFB1 induced significant alterations in EOx markers and was a genotoxic agent. In contrast, CCE reduced the number of chromosomal aberrations, DNA fragmentation, and the expression of p53 along with its associated genes (bax and bcl2). It is concluded that the genoprotective effect of CCE is probably related to its antioxidant capacity. | [73] |
In vitro In vivo | In this study, the anticancer effect of five concentrations (0.5, 1.0, 5.0, 10 or 25%) of aqueous extracts of CLD from OFI in ovarian, cervix and bladder cells was evaluated; as well as in tumor growth in Balb/C mice. | After treating the cells for 3 and 5 days, an inhibition of cell growth and induction of apoptosis was confirmed in a dose-dependent and time-dependent manner. The extracts were also found to significantly suppress tumor growth and increase annexin IV expression in animals. | [97] |
In vitro | The antiproliferative potential of betanin isolated from PPFs from OFI on the human chronic myeloid leukemia cell line (K562) was analyzed. | The results showed a decrease in the proliferation of K562 cells treated with a concentration of 40 μM. On the other hand, scanning electron microscopy revealed apoptotic characteristics such as chromatin condensation, cell contraction, and membrane blistering. While flow cytometry (FCM) showed 28% of cells in G0/G1 phase. In conclusion, betanin can induce apoptosis through the intrinsic pathway. | [98] |
In vivo | Zourgui et al., analyzed whether EOx is a relevant parameter in the toxicity induced by ZEN and evaluated the efficacy, safety and antigenotoxic capacity of CCE to prevent the deleterious effects of ZEN. Balb/C mice were treated with the mycotoxin and three doses (25, 50 and 100 mg/kg b.w.) of CCE from OFI. | The results showed that ZEN increased the level of MDA, CAT and the generation of protein carbonyls in kidney and liver. While from the lowest dose of CCE the oxidative damage induced by ZEN was reduced. On the other hand, the same toxin induced MN frequency and chromosomal aberrations in bone marrow cells. This phenomenon was reversed by the three doses of CCE; emphasizing that the highest dose of the extract was safe and did not induce any genotoxic effect. These data suggest that SCC may reduce the detrimental effects of EOx and ZEN-induced genotoxicity. | [99,100] |
In vitro | Nine PPFs juices from OFI were characterized in terms of color, pH, acidity, phenolic content, flavonoids, and betalains. The study included its antioxidant activity in vitro against four cancer cell lines [mammary (MCF-7), prostate (PC3), colon (Caco-2) and hepatic (HepG2)]. | In summary, the juices presented pH and acidity values that varied from 4.27 to 5.46 and from 0.03 to 0.27%, respectively. Variations were also observed in the content of flavonoids, betaxanthins and betacyanins. PC3 and Caco-2 were the cell lines most affected in their viability due to the action of PPF juices. | [101] |
In vitro | Given that OHF has high concentrations of polyphenols and flavonoids, the anticancer effects of an EtOAc, aqueous and hexane extract on MCF-7 cells were investigated. | All extracts significantly decreased the number of viable cells in a concentration-dependent manner. Furthermore, a G1 arrest was induced in MCF-7 cells. In general, it was evidenced that the aqueous extract had a greater capacity to inhibit cell proliferation and induce apoptosis. | [102] |
In vitro | Considering the previous studies of Yoon et al. (102) an extract of EtOAc, of hexane, and a fraction divided in water of O. humifusa (OHF) were again analyzed on cell proliferation, G1 arrest and apoptosis in U87MG human glioblastoma cells. | Cell proliferation was assessed using the MTT assay [3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide], and the effects of each extract on cell cycle and apoptosis were analyzed by FCM. The results were that both the hexane extract and the aqueous fraction reduced the number of viable cells. Furthermore, cell arrest was again induced in G1. | [103] |
In vitro | Ovarian cancer cells (OVCA420) and immortalized normal ovarian cells (SKOV3) were treated with two concentrations (5 and 10%) of an aqueous extract of prickly pear (AEPP) from OFI. | After 2 days of treatment, both types of cells treated with AEPP showed a relevant increase in ROS. Specifically, high levels of DNA fragmentation and the expression of genes related to apoptosis (Bax, Bad, caspase 3, Bcl2, p53 and p21) that are sensitive to ROS were also observed in OVCA420 cells. After three days of treatment, the expression of NF-kappa B decreased, while p-AKT increased. The conclusion was that the inhibitory effect of AEPP on cell growth is through the accumulation of ROS and induction of apoptosis. | [104] |
In vivo | Some in vitro tests have shown that OHF has anti-inflammatory, anti-proliferative and radical scavenging capabilities; Therefore, it was decided to evaluate its inhibitory effect on DMBA and TPA-induced skin cancer in Balb/C mice. | After previously feeding the animals with a diet containing 1.0 and 3.0% OHF, a reduction in the number of papillomas and epidermal hyperplasia occurred. The total antioxidant capacity, cutaneous glutathione S-transferase activity, and SOD also increased. Lipid peroxidation was measured in the skin cytosol and was only inhibited in the group fed 3% OHF. The results suggest that OHF exerts its chemoprevention by reducing EOx by modulating skin lipid peroxidation, enhancing antioxidant capacity, and inducing the phase II detoxifying enzyme system. | [105] |
In vivo | The previous result of Lee et al. [105] that determined the chemopreventive capacity of OHF on skin cancer induced by DMBA and TPA motivated this new study to analyze the protective potential of OHF against UVB-induced photocarcinogenesis. Again, Balb/C mice were fed OHF and subsequently irradiated twice every week for 30 weeks. | The final evidence was that the diet inhibited UVB-induced epidermal hyperplasia, leukocyte infiltration, myeloperoxidase level, and pro-inflammatory cytokine levels. In addition, the presence of interleukin-1β (IL-1β), IL-6, TNF-α, the level of expression of mRNA and COX-2 were reduced. Taken together, these data suggest that such protection is associated with the inhibition not only of UVB-induced inflammatory responses involving COX-2 and pro-inflammatory cytokines, but also with the down-regulation of UVB-induced cellular proliferation. | [106] |
In vitro | In this work, the residues from the juice production of PPFs derived from OFI and OR were explored as possible sources of natural chemotherapeutic ingredients against colon cancer. By means of a hydroalcoholic extraction and separation by adsorption, the natural extracts were produced and their antiproliferative effect was subsequently evaluated in the HT29 cell line (human colon carcinoma). | The results showed that the extracts inhibited cell growth and stopped the cell cycle, especially in G1, G2 and M. Betacyanins, ferulic acid and flavonoids (mainly isorhamnetin) are probably the main compounds responsible for cell cycle arrest. Besides, the death of cancer cells could have been induced by the pro-oxidant effect of these compounds. | [107] |
In vitro | To analyze the antitumor effect of the polysaccharides extracted from OdHw on cells of squamous cell carcinoma of the lung (SK-MES-1), the AnnexinV assay, FCM and Western-blotting were used. | The results showed that different concentrations of polysaccharides inhibit the growth of SK-MES-1 cells and stop the cell cycle in phase S. The AnnexinV assay revealed the induction of apoptosis. These data suggest that cell inhibition and apoptosis may be attributed to an increased expression of the P53 protein and the tension homolog deleted on chromosome ten (PTEN) protein. | [108] |
In vitro | The purpose of the research was to determine the antiproliferative effect of extracts of OFI and different isorhamnetin glycosides in two cancer cell lines (HT-29 and Caco-2). | The study showed that glycosides and extracts were more cytotoxic against HT-29 cells. A bioluminescent analysis revealed an increase in caspase 3/7 activity in cells treated with the extracts, while FCM confirmed that both extracts and glycosides induced greater apoptosis in HT-29 cells. However, isolated isorhamnetin was more apoptotic in the Caco-2 cell line. The conclusion was that glycosylation induces the antiproliferative effect exerted by isorhamnetin extracts and glycosides. | [109] |
In vitro | The research was on the effect of an AEPP derived from OFI and its pigment Ind on the proliferation of Caco-2 cells. | Both compounds caused apoptosis in nutritionally relevant amounts and their action was dose-dependent. Despite this, Ind accounted for approximately 80% of the protective effect, although not inducing EOx in Caco-2 cells. Probably, the epigenomic activity of Ind was to demethylate the promoter of the tumor suppressor gene p16 and reactivate the expression of silenced mRNA, favoring cell inhibition in the G2/M phase. | [110] |
In vitro | Initially, the bioactive compounds of different extracts (hexane, EtOAc, acetone, MeOH and MeOH: water) of cladodes from OFI were identified and quantified by HPLC. Subsequently, their chemopreventive activities were evaluated in two types of cells (MCF7 and SW480). | The results indicated that the acetone and MeOH extract showed the highest amount of polyphenolic compounds. Further to this, most of the extracts, with the exception of hexane, exhibited significant cytotoxicity in both cell lines; although the most sensitive was the SW480. These findings suggest that the cell death induced by the extracts caused an inhibition of cyclooxygenase-2 (COX-2) and increased the Bax/Bcl2 ratio, favoring apoptosis. The set of antioxidant, antiproliferative and proapoptotic activity of bioactive compounds probably promote their chemopreventive role. | [111] |
In vitro | Considering that the total levels of polyphenol and ascorbic acid in OHF are high, the premise was that their antioxidant compounds could inhibit the survival of two cell lines [cervical carcinoma (HeLa) and human BJ fibroblasts]. | Hexane extracts from their seeds and EtOAc extracts from PPFs and CLD significantly suppressed HeLa proliferation, but did not affect BJ fibroblasts. Another observation was that G1 phase arrest was induced in HeLa cells, which was associated with low levels of cyclin D1 [cyclin-dependent kinase 4 (Cdk4)]. This result motivated to examine the EtOAc extract on the tumor growth of the HeLa cell xenograft, due to the finding that the tumor volume had been reduced; which was correlated with the decrease in the expression of Cdk4 and cyclin D1. It is suggested that both extracts may be promising candidates for the treatment of human cervical carcinoma. | [112] |
In vitro | This study involved two objectives; the first, to evaluate the analgesic and anti-inflammatory activity of OMF3; and the second, to determine its antigenotoxic effects in Allium cepa test. | By means of the acetic acid contortion test and the carrageenan-induced foot edema test, OMF3 showed to have high analgesic and anti-inflammatory activity (72 and 70%, respectively). OMF3 also induced an antimutagenic potential at a concentration of 60 μg/mL against H2O2-induced damage. | [113] |
In vitro | Despite the fact that OFI is an important dietary source and a traditionally used medicinal plant, there are few studies on its toxic effects. Therefore, a toxicological evaluation was carried out using the 3-(4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazo-lium bromide (MTT), Comet and the γH2AX In-Cell Western Assay. | None of the extracts showed any cytotoxic or genotoxic effect on the HepG2 cell line; on the contrary, both the fruit pulp and the extracts of seeds, flowers and cladodes showed a protective effect against the genotoxicity induced by H2O2. This evidence suggests that OFI extracts do not have cytotoxic and/or genotoxic effects. | [114] |
5. Conclusions and Perspectives
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Mendoza-Pérez, J.A.; Fregoso-Aguilar, T.A. Chemistry of natural antioxidants and studies performed with different plants collected in Mexico. In Oxidative Stress and Chronic Degenerative Diseases-A Role for Antioxidants; Morales-González, J.A., Ed.; InTech: Rijeka, Croatia, 2013; pp. 59–85. [Google Scholar]
- Peltzer, K.; Pengpid, S. Utilization and Practice of Traditional/Complementary/Alternative Medicine (T/CAM) in Southeast Asian Nations (ASEAN) Member States. Stud. Ethno-Med. 2015, 9, 209–218. [Google Scholar] [CrossRef]
- López-Romero, D.; Izquierdo-Vega, J.A.; Morales-González, J.A.; Madrigal-Bujaidar, E.; Chamorro-Cevallos, G.; Sánchez-Gutiérrez, M.; Betanzos-Cabrera, G.; Álvarez-González, I.; Morales-González, Á.; Madrigal-Santillán, E. Evidence of Some Natural Products with Antigenotoxic Effects. Part 2: Plants, Vegetables, and Natural Resin. Nutrients 2018, 10, 1954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Madrigal-Santillán, E.; García-Melo, F.; Morales-González, J.A.; Vázquez-Alvarado, P.; Muñoz-Juárez, S.; Zuñiga-Pérez, C.; Sumaya-Martínez, M.T.; Madrigal-Bujaidar, E.; Hernández-Ceruelos, A. Antioxidant and anticlastogenic capacity of prickly pear juice. Nutrients 2013, 5, 4145–4158. [Google Scholar] [CrossRef] [Green Version]
- Angulo-Bejarano, P.I.; Martínez-Cruz, O.; Paredes-López, O. Phytochemical Content, Nutraceutical Potential and Biotechnological Applications of an Ancient Mexican Plant: Nopal (Opuntia ficus-indica). Curr. Nutr. Food Sci. 2014, 10, 196–217. [Google Scholar] [CrossRef]
- El-Mostafa, K.; El Kharrassi, Y.; Badreddine, A.; Andreoletti, P.; Vamecq, J.; El Kebbaj, M.H.S.; Latruffe, N.; Lizard, G.; Nasser, B.; Cherkaoui-Malki, M. Nopal cactus (Opuntia ficus-indica) as a source of bioactive compounds for nutrition, health and disease. Molecules 2014, 19, 14879–14901. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Del Socorro Santos Díaz, M.; Barba de la Rosa, A.P.; Héliès-Toussaint, C.; Guéraud, F.; Nègre-Salvayre, A. Opuntia spp.: Characterization and Benefits in Chronic Diseases. Oxid. Med. Cell Longev. 2017, 2017, 8634249. [Google Scholar] [CrossRef] [Green Version]
- Griffith, M.P. The origins of an important cactus crop, Opuntia ficus-indica (Cactaceae): New molecular evidence. Am. J. Bot. 2004, 91, 1915–1921. [Google Scholar] [CrossRef] [Green Version]
- Ochoa, M.J.; Giuseppe Barbera, G. History and economic and agro-ecological importance. In Crop Ecology, Cultivation and Uses of Cactus Pear; Paolo Inglese, P., Mondragon, C., Eds.; Food and Agriculture Organization of the United Nations: Rome, Italy, 2017; pp. 1–11. [Google Scholar]
- Kiesling, R.; Metzing, D. Origin and taxonomy of Opuntia ficus-indica. In Crop Ecology, Cultivation and Uses of Cactus Pear; Paolo Inglese, P., Mondragon, C., Eds.; Food and Agriculture Organization of the United Nations: Rome, Italy, 2017; pp. 13–16. [Google Scholar]
- Reyes-Agüero, J.A.; Aguirre-Rivera, J.R. Agrobiodiversity of cactus pear (Opuntia, Cactaceae) in the meridional highlands plateau of Mexico. J. Nat. Resour. Dev. 2011, 1, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Madrigal-Santillán, E.; Madrigal-Bujaidar, E.; Álvarez-González, I.; Sumaya-Martínez, M.T.; Gutiérrez-Salinas, J.; Bautista, M.; Morales-González, A.; García-Luna y González-Rubio, M.; Aguilar-Faisal, L.; Morales-González, J.A. Review of natural products with hepatoprotective effects. World J. Gastroenterol. 2014, 20, 14787–14804. [Google Scholar] [CrossRef]
- El-Samahy, S.K.; El-Hady, E.A.A.; Habiba, R.A.; Moussa, T.E. Chemical and Rheological Characteristics of Orange-Yellow Cactus-Pear Pulp from Egypt. J. Prof. Assoc. Cactus Dev. 2006, 8, 39–51. [Google Scholar]
- Osuna-Martínez, U.; Reyes-Esparza, J.; Rodríguez-Fragoso, L. Cactus (Opuntia ficus-indica): A Review on its Antioxidants Properties and Potential Pharmacological Use in Chronic Diseases. Nat. Prod. Chem. Res. 2014, 2, 153–159. [Google Scholar] [CrossRef] [Green Version]
- Kaur, M.; Kaur, A.; Sharma, R. Pharmacological actions of Opuntia ficus indica: A Review. J. Appl. Pharm. Sci. 2012, 2, 15–18. [Google Scholar] [CrossRef] [Green Version]
- Aragona, M.; Lauriano, E.R.; Pergolizzi, S.; Faggio, C. Opuntia ficus-indica (L.) Miller as a source of bioactivity compounds for health and nutrition. Nat. Prod. Res. 2018, 32, 2037–2049. [Google Scholar] [CrossRef] [PubMed]
- Dillard, C.J.; German, J.B. Phytochemicals: Nutraceuticals and human health. J. Sci. Food Agric. 2000, 80, 1744–1756. [Google Scholar] [CrossRef]
- Sarre-Álvarez, D.; Cabrera-Jardines, R.; Rodríguez-Weber, F.; Díaz-Greene, E. Atherosclerotic cardiovascular disease. Review of risk scales and cardiovascular age. Med. Int. Méx. 2018, 34, 910–923. [Google Scholar]
- Acosta-Cázares, B.; Escobedo-de la Peña, J. High burden of cardiovascular disease risk factors in Mexico: An epidemic of ischemic heart disease that may be on its way? Am. Heart J. 2010, 160, 230–236. [Google Scholar] [CrossRef]
- Pena-Valdivia, C.B.; Trejo, C.; Arroyo-Pena, V.B.; Sanchez-Urdaneta, A.B.; Balois-Morales, R. Diversity of unavailable polysaccharides and dietary fiber in domesticated nopalito and cactus pear fruit (Opuntia spp.). Chem. Biodivers. 2012, 9, 1599–1610. [Google Scholar] [CrossRef]
- Uebelhack, R.; Busch, R.; Alt, F.; Beah, Z.M.; Chong, P.W. Effects of cactus fiber on the excretion of dietary fat in healthy subjects: A doble blind, randomized, placebo-controlled, crossover clinical investigation. Curr. Ther. Res. Clin. Exp. 2014, 76, 39–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gentile, C.; Tesoriere, L.; Allegra, M.; Livrea, M.A.; D’Alessio, P. Antioxidant betalains from cactus pear (Opuntia ficus-indica) inhibit endothelial ICAM-1 expression. Ann. N. Y. Acad. Sci. 2004, 1028, 481–486. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Diez, F.; Garcia-Mediavilla, V.; Bayon, J.E.; Gonzalez-Gallego, J. Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats. J. Nutr. 1996, 126, 1766–1771. [Google Scholar] [CrossRef]
- Budinsky, A.; Wolfram, R.; Oguogho, A.; Efthimiou, Y.; Stamatopoulos, Y.; Sinzinger, H. Regular ingestion of Opuntia robusta lowers oxidation injury. Prostaglandins Leukot Essent Fatty Acids 2001, 65, 45–50. [Google Scholar] [CrossRef] [Green Version]
- Wolfram, R.M.; Kritz, H.; Efthimiou, Y.; Stomatopoulos, J.; Sinzinger, H. Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hiperlipidemia-a pilot study. Wien Klin Wochenschr. 2002, 114, 840–846. [Google Scholar]
- Oh, P.S.; Lim, K.T. Glycoprotein (90 kDa) isolated from Opuntia ficus-indica var. saboten MAKINO lowers plasma lipid level through scavenging of intracellular radicals in triton WR-1339-induced mice. Biol. Pharm. Bull. 2006, 29, 1391–1396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Osorio-Esquivel, O.; Ortiz-Moreno, A.; Garduño-Siciliano, L.; Alvarez, V.B.; Hernández-Navarro, M.D. Antihyperlipidemic effect of methanolic extract from Opuntia joconostle seeds in mice fed a hypercholesterolemic diet. Plant Foods Hum. Nutr. 2012, 67, 365–370. [Google Scholar] [CrossRef] [PubMed]
- Linarès, E.; Thimonier, C.; Degre, M. The effect of NeOpuntia on blood lipid parameters-risk factors for the metabolic syndrome (syndrome X). Adv. Ther. 2007, 24, 1115–1125. [Google Scholar] [CrossRef]
- Keller, J.; Camaré, C.; Bernis, C.; Astello-García, M.; Barba de la Rosa, A.P.; Rossignol, M.; Santos Díaz, M.S.; Salvayre, R.; Negre-Salvayre, A.; Guéraud, F. Antiatherogenic and antitumoral properties of Opuntia cladodes: Inhibition of low density lipoprotein oxidation by vascular cells, and protection against the cytotoxicity of lipid oxidation product 4-hydroxynonenal in a colorectal cancer cellular model. J. Physiol. Biochem. 2015, 71, 577–587. [Google Scholar] [CrossRef] [PubMed]
- Palumbo, B.; Efthimiou, Y.; Stamatopoulos, J.; Oguogho, A.; Budinsky, A.; Palumbo, R.; Sinzinger, H. Prickly pear induces upregulation of liver LDL binding in familial heterozygous hypercholesterolemia. Nucl. Med. Rev. Cent. East. Eur. 2003, 6, 35–39. [Google Scholar]
- Hahm, S.W.; Park, J.; Son, Y.S. Opuntia humifusastems lower blood glucose and cholesterol levels in streptozotocin-induced diabetic rats. Nutr. Res. 2011, 31, 479–487. [Google Scholar] [CrossRef]
- Zhao, L.Y.; Huang, W.; Yuan, Q.X.; Cheng, J.; Huang, Z.C.; Ouyang, L.J.; Zeng, F.H. Hypolipidaemic effects and mechanisms of the main component of Opuntia dillenii Haw. polysaccharides in high-fat emulsion-induced hyperlipidaemic rats. Food Chem. 2012, 134, 964–971. [Google Scholar] [CrossRef] [PubMed]
- Ressaissi, A.; Attia, N.; Falé, P.L.; Pacheco, R.; Victor, B.L.; Machuqueiro, M.; Serralheiro, M.L.M. Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: Cholesterol permeability, HMG-CoA reductase inhibition, and docking studies. Arch. Pharm. Res. 2017, 40, 1278–1286. [Google Scholar] [CrossRef]
- Gouws, C.; Mortazavi, R.; Mellor, D.; McKune, A.; Naumovski, N. The effects of Prickly Pear fruit and cladode (Opuntia spp.) consumption on blood lipids: A systematic review. Complement Ther. Med. 2020, 50, 102384. [Google Scholar] [CrossRef]
- Bouhrim, M.; Daoudi, N.E.; Ouassou, H.; Benoutman, A.; Loukili, E.H.; Ziyyat, A.; Mekhfi, H.; Legssyer, A.; Aziz, M.; Bnouham, M. Phenolic Content and Antioxidant, Antihyperlipidemic, and Antidiabetogenic Effects of Opuntia dillenii Seed Oil. Sci. World J. 2020, 2020, 5717052. [Google Scholar] [CrossRef] [PubMed]
- Tesoriere, L.; Attanzio, A.; Allegra, M.; Gentile, C.; Livrea, M.A. Phytochemical indicaxanthin suppresses 7-ketocholesterol-induced THP-1 cell apoptosis by preventing cytosolic Ca(2+) increase and oxidative stress. Br. J. Nutr. 2013, 110, 230–240. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garoby-Salom, S.; Guéraud, F.; Camaré, C.; Barba de la Rosa, A.P.; Rossignol, M.; Santos Díaz, M.S.; Salvayre, R.; Negre-Salvayre, A. Dietary cladode powder from wild type and domesticated Opuntia species reduces atherogenesis in apoE knock-out mice. J. Physiol. Biochem. 2016, 72, 59–70. [Google Scholar] [CrossRef] [PubMed]
- Giglio, R.V.; Carruba, G.; Cicero, A.F.G.; Banach, M.; Patti, A.M.; Nikolic, D.; Cocciadiferro, L.; Zarcone, M.; Montalto, G.; Stoian, A.P.; et al. Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites 2020, 10, 428. [Google Scholar] [CrossRef]
- Lizarzaburu-Robles, J.C. Metabolic syndrome: Concept and practical application. An. Fac. Med. 2013, 74, 315–320. [Google Scholar] [CrossRef] [Green Version]
- Holvoet, P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh. K. Acad. Geneeskd Belg. 2008, 70, 193–219. [Google Scholar] [PubMed]
- Frati-Munari, A.C.; Gordillo, B.E.; Altamirano, P.; Ariza, C.R. Hypoglycemic effect of Opuntia streptacantha Lemaire in NIDDM. Diabetes Care. 1988, 11, 63–66. [Google Scholar] [CrossRef] [PubMed]
- Gouws, C.A.; Georgousopoulou, E.N.; Mellor, D.D.; McKune, A.; Naumovski, N. Effects of the Consumption of Prickly Pear Cacti (Opuntia spp.) and its Products on Blood Glucose Levels and Insulin: A Systematic Review. Medicina 2019, 55, 138. [Google Scholar] [CrossRef] [Green Version]
- Butterweck, V.; Semlin, L.; Feistel, B.; Pischel, I.; Bauer, K.; Verspohl, E.J. Comparative evaluation of two different Opuntia ficus-indica extracts for blood sugar lowering effects in rats. Phytother. Res. 2011, 25, 370–375. [Google Scholar] [CrossRef]
- Deldicque, L.; Van Proeyen, K.; Ramaekers, M.; Pischel, I.; Sievers, H.; Hespel, P. Additive insulinogenic action of Opuntia ficus-indica cladode and fruit skin extract and leucine after exercise in healthy males. J. Int. Soc. Sports Nutr. 2013, 10, 45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berraaouan, A.; Abderrahim, Z.; Hassane, M.; Abdelkhaleq, L.; Mohammed, A.; Mohamed, B. Evaluation of protective effect of cactus pear seed oil (Opuntia ficus-indica L. MILL.) against alloxan-induced diabetes in mice. Asian Pac. J. Trop. Med. 2015, 8, 532–537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, M.; Yang, N.; Yang, B.; Jiang, Y.; Zhang, G. Structural characterization of water-soluble polysaccharides from Opuntia monacanthacladodes in relation to their anti-glycated activities. Food Chem. 2007, 105, 1480–1486. [Google Scholar] [CrossRef]
- Zhao, L.Y.; Lan, Q.J.; Huang, Z.C.; Ouyang, L.J.; Zeng, F.H. Antidiabetic effect of a newly identified component of Opuntia dillenii polysaccharides. Phytomedicine 2011, 18, 661–668. [Google Scholar] [CrossRef]
- Vincent, J.B. Chromium: Celebrating 50 years as an essential element? Dalton Trans. 2010, 39, 3787–3794. [Google Scholar] [CrossRef]
- Barlett, H.E.; Eperjesi, F. Nutritional supplementation for type 2 diabetes: A systematic review. Ophthalmic. Physiol. Opt. 2008, 28, 503–523. [Google Scholar] [CrossRef] [Green Version]
- Díaz-Medina, E.M.; Martin-Herrera, D.; Rodríguez-Rodríguez, E.M.; Díaz-Romero, C. Chromium(III) in cactus pad and its possible role in the antihyperglycemic activity. J. Funct. Foods. 2012, 4, 311–314. [Google Scholar] [CrossRef]
- Ibáñez-Camacho, R.; Meckes-Lozoya, M. Effect of a semipurified product obtained from Opuntia streptacantha L. (a cactus) on glycemia and triglyceridemia of rabbit. Arch. Investig. Med. 1983, 14, 437–443. [Google Scholar]
- Roman-Ramos, R.; Flores-Saenz, J.L.; Alarcon-Aguilar, F.J. Antihyperglycemic effect of some edible plants. J. Ethnopharmacol. 1995, 48, 25–32. [Google Scholar] [CrossRef]
- Perfumi, M.; Tacconi, R. Antihyperglycemic Effect of Fresh Opuntia dillenii Fruit from Tenerife (Canary Islands). Pharm. Biol. 2008, 34, 41–47. [Google Scholar] [CrossRef]
- Trejo-González, A.; Gabriel-Ortiz, G.; Puebla-Pérez, A.M.; Huízar-Contreras, M.D.; Munguía-Mazariegos, M.R.; Mejía-Arreguín, S.; Calva, E. A purified extract from prickly pear cactus (Opuntia fuliginosa) controls experimentally induced diabetes in rats. J. Ethnopharmacol. 1996, 55, 27–33. [Google Scholar] [CrossRef]
- Abdallah, I.Z. Evaluation of Hypoglycemic Activity of Opuntia dillenii Haw Fruit Juice in Streptozotocin-Induced Diabetic Rats. Egypt J. Hosp. Med. 2008, 33, 544–558. [Google Scholar] [CrossRef]
- Luo, C.; Zhang, W.; Sheng, C.; Zheng, C.; Yao, J.; Miao, Z. Chemical composition and antidiabetic activity of Opuntia Milpa Alta extracts. Chem. Biodivers. 2010, 7, 2869–2879. [Google Scholar] [CrossRef] [PubMed]
- Yoon, J.A.; Lee, S.J.; Kim, H.K.; Son, Y.S. Ameliorating effects of a nopal (Opuntia ficus-indica) complex on blood glucose in db/db mice. Food Sci. Biotechnol. 2011, 20, 255–259. [Google Scholar] [CrossRef]
- Chong, P.-W.; Lau, K.-Z.; Gruenwald, J.; Uebelhack, R. A Review of the Efficacy and Safety of Litramine IQP-G-002AS, an Opuntia ficus-indica Derived Fiber for Weight Management. Evid. Based Complement Alternat Med. 2014, 2014, 943713. [Google Scholar] [CrossRef]
- Rodríguez-Rodríguez, C.; Torres, N.; Gutiérrez-Uribe, J.A.; Noriega, L.G.; Torre-Villalvazo, I.; Leal-Díaz, A.M.; Antunes-Ricardo, M.; Márquez-Mota, C.; Ordaz, G.; Chavez-Santoscoy, R.A.; et al. The effect of isorhamnetin glycosides extracted from Opuntia ficus-indica in a mouse model of diet induced obesity. Food Funct. 2015, 6, 805–815. [Google Scholar] [CrossRef]
- Shapiro, K.; Gong, W.C. Natural products used for diabetes. J. Am. Pharm. Assoc. 2002, 42, 217–226. [Google Scholar] [CrossRef] [PubMed]
- Laurenz, J.C.; Collier, C.C.; Kuti, J.O. Hypoglycaemic effect of Opuntia lindheimeri Englem in a diabetic pig model. Phytother Res. 2003, 17, 26–29. [Google Scholar] [CrossRef]
- Godard, M.P.; Ewing, B.A.; Pischel, I.; Ziegler, A.; Benedek, B.; Feistel, B. Acute blood glucose lowering effects and long-term safety of OpunDia supplementation in pre-diabetic males and females. J. Ethnopharmacol. 2010, 130, 631–634. [Google Scholar] [CrossRef]
- Andrade-Cetto, A.; Wiedenfeld, H. Anti-hyperglycemic effect of Opuntia streptacantha Lem. J. Ethnopharmacol. 2011, 133, 940–943. [Google Scholar] [CrossRef]
- Van Proeyen, K.; Ramaekers, M.; Pischel, I.; Hespel, P. Opuntia ficus-indica ingestion stimulates peripheral disposal of oral glucose before and after exercise in healthy men. Int. J. Sport Nutr. Exerc. Metab. 2012, 22, 284–291. [Google Scholar] [CrossRef] [PubMed]
- Nuñez-López, M.A.; Paredes-López, O.; Reynoso-Camacho, R. Functional and hypoglycemic properties of nopal cladodes (O. ficus-indica) at different maturity stages using in vitro and in vivo tests. J. Agric. Food Chem. 2013, 61, 10981–10986. [Google Scholar] [CrossRef] [PubMed]
- Ennouri, M.; Fetoui, H.; Bourret, E.; Zeghal, N.; Guermazi, F.; Attia, H. Evaluation of some biological parameters of Opuntia ficus indica. 2. Influence of seed supplemented diet on rats. Bioresour. Technol. 2006, 97, 2136–2140. [Google Scholar] [CrossRef] [PubMed]
- Onakpoya, I.J.; O’Sullivan, J.; Heneghan, C.J. The effect of cactus pear (Opuntia ficus-indica) on body weight and cardiovascular risk factors: A systematic review and meta-analysis of randomized clinical trials. Nutrition 2015, 31, 640–646. [Google Scholar] [CrossRef] [PubMed]
- Alonso-Castro, A.J.; Domínguez, F.; Zapata-Morales, J.R.; Carranza-Álvarez, C. Plants used in the traditional medicine of Mesoamerica (Mexico and Central America) and the Caribbean for the treatment of obesity. J. Ethnopharmacol. 2015, 175, 335–345. [Google Scholar] [CrossRef]
- Wiese, J.; McPherson, S.; Odden, M.C.; Shlipak, M.G. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch. Intern. Med. 2004, 164, 1334–1340. [Google Scholar] [CrossRef]
- Galati, E.M.; Mondello, M.R.; Lauriano, E.R.; Taviano, M.F.; Galluzzo, M.; Miceli, N. Opuntia ficus indica (L.) Mill. fruit juice protects liver from carbon tetrachloride-induced injury. Phytother. Res. 2005, 19, 796–800. [Google Scholar] [CrossRef]
- Ncibi, S.; Ben Othman, M.; Akacha, A.; Krifi, M.N.; Zourgui, L. Opuntia ficus indica extract protects against chlorpyrifos induced damage on mice liver. Food Chem. Toxicol. 2008, 46, 797–802. [Google Scholar] [CrossRef]
- Brahmi, D.; Ayed, Y.; Bouaziz, C.; Zourgui, L.; Hassen, W.; Bacha, H. Hepatoprotective effect of cactus extract against carcinogenicity of benzo(a)pyrene on liver of Balb/C mice. J. Med. Plants Res. 2011, 5, 4627–4639. [Google Scholar]
- Brahmi, D.; Bouaziz, C.; Ayed, Y.; Ben Mansour, H.; Zourgui, L.; Bacha, H. Chemopreventive effect of cactus Opuntia ficus indica on oxidative stress and genotoxicity of aflatoxin B1. Nutr. Metab. 2011, 8, 73–89. [Google Scholar] [CrossRef] [Green Version]
- Alimi, H.; Hfaeidh, N.; Mbarki, S.; Bouoni, Z.; Sakly, M.; Rouma, K.B. Evaluation of Opuntia ficus indica f. inermis fruit juice hepatoprotective effect upon ethanol toxicity in rats. Gen. Physiol. Biophys. 2012, 31, 335–342. [Google Scholar] [CrossRef]
- Al-Kubaisy, K.N.; Al-Essa, L.Y.; Shawagfeh, M.T. Stimulation of Hepatocytes Repair by Fruit Juice of Opuntia ficus indica in Anti Cancer Drug Cyclophosphamide (CP)-Induced Liver Toxicity in Mice. Annu. Res. Rev. Biol. 2016, 10, 1–8. [Google Scholar] [CrossRef]
- González-Ponce, H.A.; Martínez-Saldaña, M.C.; Rincón-Sánchez, A.R.; Sumaya-Martínez, M.T.; Buist-Homan, M.; Faber, K.N.; Moshage, H.; Jaramillo-Juárez, F. Hepatoprotective Effect of Opuntia robusta and Opuntia streptacantha Fruits against Acetaminophen-Induced Acute Liver Damage. Nutrients 2016, 8, 607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shirazinia, R.; Golabchifar, A.A.; Rahimi, V.B.; Jamshidian, A.; Samzadeh-Kermani, A.; Hasanein, P.; Hajinezhad, M.; Askari, V.R. Protective Effect of Opuntia dillenii Haw Fruit against Lead Acetate-Induced Hepatotoxicity: In Vitro and In Vivo Studies. Evid. Based Complement Altern. Med. 2021, 2021, 6698345. [Google Scholar] [CrossRef] [PubMed]
- Nakahara, T.; Mitoma, C.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Uchi, H.; Yan, X.; Hachisuka, J.; Chiba, T.; Esaki, H.; et al. Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes. J. Med. Food. 2015, 18, 1143–1149. [Google Scholar] [CrossRef]
- Li, W.; Lin, K.; Zhou, M.; Xiong, Q.; Li, C.; Ru, Q. Polysaccharides from Opuntia milpa alta alleviate alloxan-induced INS-1 cells apoptosis via reducing oxidative stress and upregulating Nrf2 expression. Nutr. Res. 2020, 77, 108–118. [Google Scholar] [CrossRef]
- Adewoyin, M.; Ibrahim, M.; Roszaman, R.; Md Isa, M.L.; Alewi, N.A.M.; Abdul Rafa, A.A.; Nasyriq Anuar, M.N. Male Infertility: The Effect of Natural Antioxidants and Phytocompounds on Seminal Oxidative Stress. Diseases 2017, 5, 9. [Google Scholar] [CrossRef]
- Kumar, N.; Singh, A.K. Trends of male factor infertility, an important cause of infertility: A review of literature. J. Hum. Reprod. Sci. 2015, 8, 191–196. [Google Scholar] [CrossRef] [PubMed]
- Agarwal, A.; Virk, G.; Ong, C.; du Plessis, S.S. Effect of oxidative stress on male reproduction. World J. Mens. Health 2014, 32, 1–17. [Google Scholar] [CrossRef] [Green Version]
- Fujii, J.; Imai, H. Redox reactions in mammalian spermatogenesis and the potential targets of reactive oxygen species under oxidative stress. Spermatogenesis 2014, 4, e979108. [Google Scholar] [CrossRef] [Green Version]
- Sarkar, O.; Bahrainwala, J.; Chandrasekaran, S.; Kothari, S.; Mathur, P.P.; Agarwal, A. Impact of inflammation on male fertility. Front. Biosci. 2011, 3, 89–95. [Google Scholar] [CrossRef] [Green Version]
- Kashou, A.H.; Plessis, S.S.; Agarwal, A. The Role of Obesity in ROS Generation and Male Infertility. In Studies on Men’s Health and Fertility; Humana Press: New York, NY, USA, 2012; pp. 571–590. [Google Scholar]
- Close, C.E.; Roberts, P.L.; Berger, R.E. Cigarettes, alcohol and marijuana are related to pyospermia in infertile men. J. Urol. 1990, 144, 900–903. [Google Scholar] [CrossRef]
- Rahman, M.S.; Kwon, W.S.; Lee, J.S.; Yoon, S.J.; Ryu, B.Y.; Pang, M.G. Bisphenol-A affects male fertility via fertility-related proteins in spermatozoa. Sci. Rep. 2015, 5, 9169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sheweita, S.A.; Tilmisany, A.M.; Al-Sawaf, H. Mechanisms of male infertility: Role of antioxidants. Curr. Drug Metab. 2005, 6, 495–501. [Google Scholar] [CrossRef] [Green Version]
- Crha, I.; Hruba, D.; Ventruba, P.; Fiala, J.; Totusek, J.; Visnova, H. Ascorbic acid and infertility treatment. Cent. Eur. J. Public Health 2003, 11, 63–67. [Google Scholar] [PubMed]
- Meama, M.; Zribi, N.; Cambi, M.; Tamburrino, L.; Marchiani, S.; Filimberti, E.; Grazia Fino, M.; Biggeri, A.; Menezo, Y.; Forti, G.; et al. Sperm DNA fragmentation induced by cryopreservation: New insights and effect of a natural extract from Opuntia ficus-indica. Fertil. Steril. 2012, 98, 326–333. [Google Scholar] [CrossRef]
- Dattilo, M.; Cornet, D.; Amar, E.; Cohen, M.; Menezo, Y. The importance of the one carbon cycle nutritional support in human male fertility: A preliminary clinical report. Reprod Biol. Endocrinol. 2014, 12, 71. [Google Scholar] [CrossRef] [Green Version]
- Hfaiedh, M.; Brahmi, D.; Zourgu, L. Protective role of cactus cladodes extract on sodium dichromate-induced testicular injury and oxidative stress in rats. Biol. Trace. Elem. Res. 2014, 159, 304–311. [Google Scholar] [CrossRef]
- Ramya, M.C.; Shivabasavaiah; Shivanandappa, T. Reversible antifertility effect of Opuntia elatior Mill. fruit extract. Int. J. Reprod Contracept. Obstet. Gynecol. 2015, 4, 392–397. [Google Scholar] [CrossRef] [Green Version]
- Akacha, A.; Badraoui, R.; Rebai, T.; Zourgui, L. Effect of Opuntia ficus indica extract on methotrexate-induced testicular injury: A biochemical, docking and histological study. J. Biomol. Struct. Dyn. 2020, 11, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Koh, Y.C.; Ho, C.T.; Pan, M.H. Recent advances in cancer chemoprevention with phytochemicals. J. Food Drug. Anal. 2020, 28, 14–37. [Google Scholar] [CrossRef]
- Palevitch, D.; Earon, G.; Levin, I. Treatment of benign prostatic hypertrophy with Opuntia ficus-indica (L.) Miller. J. Herbs Spices Med. Plants 1993, 2, 45–49. [Google Scholar] [CrossRef]
- Zou, D.; Brewer, M.; Garcia, F.; Feugang, J.M.; Wang, J.; Zang, R.; Liu, H.; Zou, C. Cactus pear: A natural product in cancer chemoprevention. Nutr. J. 2005, 4, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sreekanth, D.; Arunasree, M.K.; Roy, K.R.; Reddy, T.C.; Reddy, G.V.; Reddanna, P. Betanin a betacyanin pigment purified from fruits of Opuntia ficus-indica induces apoptosis in human chronic myeloid leukemia Cell line-K562. Phytomedicine 2007, 14, 739–746. [Google Scholar] [CrossRef] [PubMed]
- Zourgui, L.; Golli, E.E.; Bouaziz, C.; Bacha, H.; Hassen, W. Cactus (Opuntia ficus-indica) cladodes prevent oxidative damage induced by the mycotoxin zearalenone in Balb/C mice. Food Chem. Toxicol. 2008, 46, 1817–1824. [Google Scholar] [CrossRef]
- Zorgui, L.; Ayed-Boussema, I.; Ayed, Y.; Bacha, H.; Hassen, W. The antigenotoxic activities of cactus (Opuntia ficus-indica) cladodes against the mycotoxin zearalenone in Balb/c mice: Prevention of micronuclei, chromosome aberrations and DNA fragmentation. Food Chem. Toxicol. 2009, 47, 662–667. [Google Scholar] [CrossRef] [PubMed]
- Chavez-Santoscoy, R.A.; Gutierrez-Uribe, J.A.; Serna-Saldívar, S.O. Phenolic composition, antioxidant capacity and in vitro cancer cell cytotoxicity of nine prickly pear (Opuntia spp.) juices. Plant Foods Hum. Nutr. 2009, 64, 146–152. [Google Scholar] [CrossRef] [PubMed]
- Yoon, J.A.; Hahm, S.W.; Park, J.; Son, Y.S. Total polyphenol and flavonoid of fruit extract of Opuntia humifusa and its inhibitory effect on the growth of MCF-7 human breast cancer cells. J. Korean Soc. Food Sci. Nutr. 2009, 32, 1679–1684. [Google Scholar] [CrossRef]
- Hahm, S.W.; Park, J.; Son, Y.S. Opuntia humifusapartitioned extracts inhibit the growth of U87MG human glioblastoma cells. Plant Foods Hum. Nutr. 2010, 65, 247–252. [Google Scholar] [CrossRef]
- Feugang, J.M.; Ye, F.; Zhang, D.Y.; Yu, Y.; Zhon, M.; Zhang, S.; Zou, C. Cactus pear extracts induce reactive oxygen species production and apoptosis in ovarian cancer cells. Nutr. Cancer. 2010, 62, 692–699. [Google Scholar] [CrossRef]
- Lee, J.A.; Jung, B.G.; Lee, B.J. Inhibitory effects of Opuntia humifusa on 7, 12-dimethyl- benz[a]anthracene and 12-O-tetradecanoylphorbol-13- acetate induced two-stage skin carcinogénesis. Asian Pac. J. Cancer Prev. 2012, 13, 4655–4660. [Google Scholar] [CrossRef] [Green Version]
- Lee, J.A.; Jung, B.G.; Kim, T.H.; Lee, S.G.; Park, Y.S.; Lee, B.J. Dietary feeding of Opuntia humifusa inhibits UVB radiation-induced carcinogenesis by reducing inflammation and proliferation in hairless mouse model. Photochem. Photobiol. 2013, 89, 1208–1215. [Google Scholar] [CrossRef] [PubMed]
- Serra, A.T.; Poejo, J.; Matias, A.A.; Bronze, M.R.; Duarte, C.M.M. Evaluation of Opuntia spp. derived products as antiproliferative agents in human colon cancer cell line (HT29). Food Res. Int. 2013, 54, 892–901. [Google Scholar] [CrossRef]
- Li, W.; Wu, D.; Wei, B.; Wang, S.; Sun, H.; Li, X.; Zhang, F.; Zhang, C.; Xin, Y. Anti-tumor effect of cactus polysaccharides on lung squamous carcinoma cells (SK-MES-1). Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 99–104. [Google Scholar] [CrossRef] [Green Version]
- Antunes-Ricardo, M.; Moreno-García, B.E.; Gutiérrez-Uribe, J.A.; Aráiz-Hernández, D.; Alvarez, M.M.; Serna-Saldivar, S.O. Induction of apoptosis in colon cáncer cells treated with isorhamnetin glycosides from Opuntia ficus-indica pads. Plant Foods Hum. Nutr. 2014, 69, 331–336. [Google Scholar] [CrossRef] [PubMed]
- Naselli, F.; Tesoriere, L.; Caradonna, F.; Bellavia, D.; Attanzio, A.; Gentile, C.; Livrea, M.A. Anti-proliferative and pro-apoptotic activity of whole extract and isolated indicaxanthin from Opuntia ficus-indica associated with re-activation of the onco-suppressor p16(INK4a) gene in human colorectal carcinoma (Caco-2) cells. Biochem. Biophys. Res. Commun. 2014, 450, 652–658. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.; Soh, S.Y.; Shin, J.; Cho, C.W.; Choi, Y.H.; Nam, S.Y. Bioactives in cactus (Opuntia ficus-indica) stems possess potent antioxidant and pro-apoptotic activities through COX-2 involvement. J. Sci. Food Agric. 2015, 95, 2601–2606. [Google Scholar] [CrossRef]
- Hahm, S.W.; Park, J.; Oh, S.Y.; Lee, C.W.; Park, K.Y.; Kim, H.; Son, Y.S. Anticancer properties of extracts from Opuntia humifusa against human cervical carcinoma cells. J. Med. Food 2015, 18, 31–44. [Google Scholar] [CrossRef]
- Chahdoura, H.; El Bok, S.; Refifa, T.; Adouni, K.; Khemiss, F.; Mosbah, H.; Ben-Attia, M.; Flamini, G.; Achour, L. Activity of anti-inflammatory, analgesic and antigenotoxic of the aqueous flower extracts of Opuntia microdasys Lem.Pfeiff. J. Pharm. Pharmacol. 2017, 69, 1056–1063. [Google Scholar] [CrossRef]
- Tsafantakis, N.; Katsanou, E.S.; Kyriakopoulou, K.; Psarou, E.C.; Raptaki, I.; Skaltsounis, A.L.; Audebert, M.; Machera, K.A.; Fokialakis, N. Comparative UHPLC-HRMS Profiling, Toxicological Assessment, and Protection Against H2O2-Induced Genotoxicity of Different Parts of Opuntia ficus indica. J. Med. Food 2019, 22, 1280–1293. [Google Scholar] [CrossRef]
- Eleojo Aruwa, C.; Amoo, S.O.; Kudanga, T. Opuntia (Cactaceae) plant compounds, biological activities and prospects—A comprehensive review. Food Res. Int. 2018, 112, 328–344. [Google Scholar] [CrossRef] [PubMed]
Chemical Group | Bioactive Compound |
---|---|
Cladodes (CLD) | |
Flavonoids | Quercetin (2.0–40 mg/100 g), isoquercetin (2.29–39.67 mg/100 g), isorhamnetin-3-O-glucoside (4.59–32.21 mg/100 g), kaempferol (2.2 g/kg), nicotiflorin (2.89–146.5 mg/100 g), rutin (2.36–26.17 mg/100 g) |
Phenoliccompounds | Gallic acid (0.6–2 mg/100 g), coumaric (14–16 mg/100 g), 3,4-dihydroxybenzoic (0.06–5.0 mg/100 g), 4-hydroxybenzoic, ferulic acid (0.5–34 mg/100 g) |
Amino acids | Glu (36 g/100 g), Arg (5.0 g/100 g), Leu (2.7 g/100 g), Ile (3.97 g/100 g), Lys (5.2 g/100 g), Val (7.7 g/100 g), Phe (3.5 g/100 g), Glu (36.1 g/100 g |
Minerals | K and Ca (mainly calcium oxalate crystals). Amounts ranging from 230 to 5500 mg/100 g |
Vitamins | E (2182 mg/100 g), A (7–10 mg/100 g), C (7–22 mg/100 g), B1 (0.14 mg/100 g), B2 (0.60 mg/100 g), B3 (0.46 mg/100 g) |
Prickly pear fruits (tunas) | |
Flavonoids | Kaempferol(53.2 mg/100 g), quercetin(90 μg/g), isorhamnetin(49.4 μg/g) |
Amino acids | Lys (0.63 g/100 g), Met (2.0 g/100 g), Glu (12.5 g/100 g), Taurine (15.7 g/100 g) |
Minerals | K (161 mg/100 g), Ca (27 mg/100 g), Mg (27 mg/100 g) |
Vitamins | E (527 mg/100 g), A (5 mg/100 g), C (34–40 mg/100 g) |
Organic acids | Maleic, malonic, succinic, tartaric, and oxalic. Total average of 0.36 to 8.50 mg/g |
Betalains | Betaxanthins (25.4 mg indicaxanthins/100 g), Betacyanins (15.2 mg betanin/100 g), Betalains (40.6 mg/100 g) |
Seeds | |
Phenolic compounds | Ferulic acid (3–17 mg/100 g), sinapoyl-diglucoside (13–22 mg/100 g), synapoyl-glucose, feruloyl-sucrose (8–17 mg/100 g). Total average of compounds 48–89 mg/100 g |
Minerals | Mainly K and P (160–150 mg/100 g). Lower proportions of Mg (70 mg/100 g), Na (66 mg/100 g) and Ca (16 mg/100 g) |
Sterols | β-sitosterol (67.0–21.0 g/kg) and campesterol (1.6–8.7 g/kg) |
Fatty acids | Palmitic acid (9–20 g/100 g), oleic acid (16–18 g/100 g), linoleic acid (53–70 g/100 g) |
Pulp and peel | |
Flavonoids | Quercetin (4–9 mg/100 g), isorhamnetin (3–90 mg/100 g), kaempferol (0.2–0.8 mg/100 g), luteolin (0.8–1.0 mg/100 g), isorhamnetin glycosides (50–60 mg/100 g) |
Phenolic compounds | Ferulic acid, sinapoyl-diglucoside, feruloyl-sucrose isomer. Total average of compounds 218.8 mg/100 g |
Minerals | More K (161 mg/100 g) than Ca and Mg |
Sterols | β-sitosterol (67.0–21.0 g/kg) and campesterol (1.6–8.7 g/kg) |
Fatty acids | Palmitic acid (34 g/100 g), oleic acid (10.8 g/100 g), linoleic acid (37 g/100 g), linolenic acid (12.6 g/100 g) |
Flowers | |
Flavonoids | Kaempferol (300–400 mg/100 g), quercetin (400–700 mg/100 g), isorhamnetin glycosides [isorhamnetin 3-O-robinobioside (4269 mg/100 g), isorhamnetin 3-O-galactoside (979 mg/100 g), isorhamnetin 3-O-glucoside (724 mg/100 g)] |
Organic acids | Mainly gallic acid (1600–4900 mg/100 g) |
Type of Study | Objective and Characteristics | Results and Conclusion | Ref. |
---|---|---|---|
Diabetes | |||
Clinical study | This is a pilot study where the effect of PPFs consumption on glucose metabolism was observed in 24 non-diabetic and non-obese men with FH. | The results showed a decrease in blood glucose (11%), insulin (11%), uric acid (10%) and TG (12%); while their body weight and HDL-Cho remained unchanged. This hypoglycemic action is related to an improvement in insulin sensitivity, and possibly to the pectin contained in PPFs. | [25] |
In vivo | This study was on the intake of three doses of OHF (150, 250 and 500 mg/kg/day) regarding the regulation of blood glucose and hypolipidemic responses in diabetic rats induced by STZ. | After 7 weeks of oral treatment, fasting TG and blood glucose levels were significantly lower compared to the DM control group. In addition, the group treated with 500 mg/kg showed an increase in the relative volume of pancreatic β cells. | [31] |
In vivo | The total phenolic content and the antioxidant activity of the seed oil of OdHw were analyzed using the Folin-Ciocalteu method and DPPH-scavenging assay, respectively. Also, the preventive effect of OdHw against alloxane (Allox)–induced DM was evaluated in albino mice. | The results showed that it had a high phenolic content and significant DPPH purifying activity. Likewise, the loss of body weight and the mortality rate caused by Allox decreased and the blood sugar level was controlled; which suggests that these protective actions are related to its phenolic content. | [35] |
Clinical study | The hypoglycemic effect of O. streptacantha (OS) was evaluated in 16 patients with non-insulin-dependent diabetes mellitus (NIDDM). | Their serum glucose and insulin levels were quantified at 0, 60, 120 and 180 min. The result was that both parameters significantly decreased in individuals who ingested 500 g of roasted nopal stems. It was suggested to extend the studies in order to clarify the mechanism of action of OS. | [41] |
Systematic review | The aim of this review was to identify the effects of Opuntia spp. consumption on glucose and insulin in humans, taking into account components such as PPFs, CLD and combined products. | During the research with six electronic databases, twenty articles were obtained (4 with PPFs, 12 with CLD and 4 with other products) that demonstrated a relevant reduction in serum glucose and insulin. The conclusions were that studies that specifically use PPFs or CLD have a high risk of bias. Apparently, PPFs have no significant effects on these parameters; unlike cladodes, which are more promising for hypoglycemic effects. | [42] |
In vivo | Considering that only few data exist on OFI stem and fruit preparation combinations, the purpose of this study was to investigate the effects of an aqueous extract of CLD and a patented fruit stem/skin blend (ratio: 75/25) on blood glucose and plasma insulin in normal rats. | The observations were that the aqueous extract lowers glucose in a range of 6 and 176 mg/kg; while the patented blend was at 6 mg/kg. In addition, the mixture increases plasma insulin levels. The results suggest that both extracts have hypoglycemic activity, but the potential of the mixture is more significant as it shows a direct action on pancreatic β cells. | [43] |
Clinical study | Considering the research of Van Proeyen et al. (63), the level of insulin stimulation by action of OFI combined with leucine (Leu) was compared. It was a randomized double-blind crossover study, where 11 subjects underwent an OGTT test after a cycling session. The study included an evaluation on whether this combination has an additive action on insulin stimulation after exercise. | After 60 min, the individuals ingested glucose and three types of capsules (some with 1000 mg OFI, others with a combination of OFI and Leu, and those with only Leu). Blood glucose and serum insulin were measured. The data showed that only the OFI group reduced blood glucose and the area under the glucose curve (AUGC). Furthermore, the OFI plus Leu group increased serum insulin concentration; suggesting that this combination may stimulate carbohydrate-induced insulin after doing exercise. | [44] |
In vivo | Berraaouan et al., calculated the in vitro antioxidant potential of OFI seed oil (CPSO) and its protective effect against Allox-induced diabetes mellitus. | They used a DPPH-scavenging assay for the first objective. To evaluate the preventive effect, Swiss albino mice treated with CPSO (2 mL/kg, orally) were used before and after Allox administration. During the in vivo test, body weight and fasting blood glucose were measured and a histopathological analysis of the pancreas took place. CPSO showed a relevant antioxidant action; it also reduced hyperglycemia and protected the islets of langerhans against Allox-induced tissue changes. The conclusion is that CPSO decreases oxidative stress and inhibits lesions in pancreatic β cells. | [45] |
In vitro | The objective was to analyze some ethanol fractions of cladode polysaccharides of O. monacantha (POMC). | POMC fractions IV and V were obtained by means of anion exchange chromatography and purified with a Sephadex G-50 gel filtration column. By gel permeation chromatography (GPC), high-performance liquid chromatography (HPLC) and gas chromatography (GC) it was established that POMC V had a molecular weight of 28.7 kDa and consisted mainly of rhamnose, arabinose and glucose; while POMC VI, had a smaller molecular weight (10.8 kDa) and was composed by rhamnose, mannose and glucose. | [46] |
In vivo | The purpose of this study was to determine the most effective hypoglycemic component of OdHw polysaccharides and to study their antidiabetic ability in STZ-induced diabetic mice. | Initially, three types were identified (ODP-Ia, ODP-Ib, and ODP-II). After the administration of the ODP-Ia type, the food intake, blood glucose, and TG levels significantly decreased when measured in the fasting state. However, ODP-Ia did not increase insulin levels. It is suggested that ODP-Ia exerts its antihyperglycemic effect by protecting the liver and improving its sensitivity and cellular response. | [47] |
In vivo | The aim of this research was to evaluate the effects of cactus pads extracts and pulp fruit on blood glucose concentration and the glycemic curve in Sprague-Dawley rats. | After 8 days of daily intake, the peaks and glycemic curves of the cactus pads and pulp fruit groups and the Cr (III) batch were less pronounced than those of the control group. In addition, a slight decrease in fasting blood glucose resulted. These data suggest that the Cr (III) content in these plant foods is related to their antihyperglycemic capacity. | [50] |
In vivo | Ibañez and Meckes analyzed the hypoglycemic effect of a semi-purified fraction of OS in rabbits. | They confirmed that the powder fraction obtained produces an effect similar to the whole extract traditionally obtained from the stems of the vegetable. Their results suggest that the semi-purified product requires further evaluation to be considered a hypoglycemic agent. | [51] |
In vivo | The antihyperglycemic effect of some edible plants (Cucurbita ficifolia, Phaseolus vulgaris, OS, Spinacea oleracea, and Cucumis sativus) was analyzed in healthy rabbits subjected to weekly tests of subcutaneous glucose tolerance. | Most of the plants had this capacity. However, OS was the one that most significantly decreased the area under the glucose tolerance curve and the hyperglycemic peak. | [52] |
In vivo | Given that OdHw is traditionally used in the Canary Islands, the effect of its red juice on blood glucose levels in normoglycemic and Allox-induced diabetic rabbits was tested. | An oral dose of 5.0 mL/kg significantly reduced the increase in hyperglycemia in both types of rabbits. OdHw did not increase plasma insulin levels and was similar to that of an oral dose of tolbutamide (100 mg/kg). These data suggest that OdHw produces hypoglycemia mainly by reducing intestinal glucose absorption. | [53] |
In vivo | The study was on hypoglycemic activity of an purified extract of O. fuliginosa (Of) in induced diabetic rats by STZ. | Blood glucose and glycated hemoglobin (HbA1c) levels were reduced to normal values by a combined treatment of insulin and extract. When the insulin was with-drawn from the combination treatment, the extract maintained the normoglycemic state in the diabetic rats. The mechanism of action induced by the dose of Of (1.0 mg/kg/day) is possibly related to its fiber content. | [54] |
In vivo | The purpose of the study was to evaluate the nutritional value of OdHw and its curative potential in STZ-induced diabetic rats. | The results showed that OdHw is a rich source of fiber, carbohydrates, minerals and vitamins. In addition, oral administration of OdHw juice significantly reduced blood glucose levels and by means of a histopathological analysis of pancreatic tissue improvement in the cells of the islets of Langerhans was observed, which may explain the antidiabetic effect of OdHw. | [55] |
In vivo | The effects of some extracts of O. Milpa Alta [Aqueous, petroleum ether, ethyl acetate (EtOAc), butanol (BuOH)] were tested in STZ-induced diabetic mice. | The results indicated that all the extracts managed to lower glucose levels; although petroleum ether extract was the most significant. | [56] |
In vivo | This study focused on the effect of OFI on blood glucose metabolism of db/db mice treated for 4 weeks. | After this period, food intake, plasma glucose and insulin levels decreased markedly. Furthermore, a histopathological analysis showed that the morphology of the pancreatic islets improved in the animals treated with OFI. | [57] |
Systematic review | The purpose of the investigation was to analyze the efficacy of some natural products (Opuntia, Gymnema, Tecoma, Ginseng, Karela, Alpha lipoic and Panaxans) commonly used for diabetes. | After a MEDLINE search of articles published between 1960 and 2001, nopal was found to be the most widely used herbal hypoglycemic agent in people of Mexican descent; while Karela is mainly used in Asian countries. Studies reveal different mechanisms of action, among which the high content of soluble fiber stands out. | [60] |
In vivo | The hypoglycemic activity of an extract of O. lindheimeri Englem was investigated in STZ-induced diabetic pigs. | A dose-dependent decrease in blood glucose concentration resulted from the oral administration of two doses (250 and 500 mg/kg) of the extract. Furthermore, the greatest hypoglycemic effect appeared 4 h after the intake. The conclusion is that this experimental model can be useful to evaluate long-term effects of Opuntia consumption given the physiological similarities of pigs with humans. | [61] |
Clinical study | A double-blind controlled study (obese prediabetic individuals of both genders) was performed on the acute and chronic effects of OFI. The OGTT test was evaluated with a bolus of 400 mg of OFI ingested 30 min before consuming glucose. | In the acute phase, a significant decrease in blood glucose concentrations was observed during the next 60, 90 and 120 min. On the contrary, in the chronic phase, no differences were observed with the evaluated schedules of the OGTT, in the blood chemistry variables (insulin, adiponectin, Hb1Ac) and in the body composition after 16 weeks of supplying 200 mg of OFI. | [62] |
In vivo | Two extracts of O. streptacantha [cladode traditional extract (LE) and traditional filtered sample (FE)] were evaluated in diabetic rats with STZ by two tests. | The first was to confirm its hypoglycemic capacity (LE 135 mg/kg and FE 27 mg/kg) and the second was to quantify the antihyperglycemic potential using oral glucose tolerance test (OGTT). The conclusion was that both extracts did not produce a significant hypoglycemic effect but an antihyperglycemic action compared to a control group of animals. | [63] |
Clinical study | Healthy men participated in a double-blind crossover study that included 2 experimental sessions. In the first one, they underwent OGTT at rest (OGTT-R) and cycling activity for 30 min. Immediately after the exercise, they received capsules containing 1000 mg of OFI extract and another OGTT (-EX) was performed. | Blood samples were collected at baseline and at 30-min intervals after the ingestion of 75 g of glucose in order to determine blood glucose and serum insulin. The results indicated that in OGTT-R, the AUGC was reduced by 26% and serum insulin had a higher concentration; while in OGTT-EX, glucose decreased approximately 10% lower with OFI compared to the placebo group. In conclusion, the extract can increase plasma insulin and facilitate the removal of an oral glucose load from the circulation at rest and after doing exercise. | [64] |
In vitro In vivo | There is no information about whether the maturity stage in OFI can alter its antidiabetic capacity. Thus, the effect of small (SCF), medium (MCF) and large (LCF) cladode flours in diabetic rats was analyzed. | Only the MCF and SCF batches (50 mg/kg dose) showed a reduction in postprandial blood glucose. Furthermore, in vitro glucose diffusion tests showed a similar classification in both types of flour. It is considered was that the maturity stage alters the fiber content and produces differences in its viscosity, affecting in vitro and in vivo glucose responses. | [65] |
Obesity | |||
Systematic review | A sedentary lifestyle and excessive calorie consumption are known to be key factors in the prevalence of obesity. In consequence, reducing dietary fat absorption through approved drugs and natural treatments could help control this health problem. | Information gathered from four randomized controlled clinical studies on the efficacy of Litramine IQP-G-002AS (fiber derived from OFI) in reducing fat absorption suggests that it is effective in promoting fat excretion and weight loss; especially when ingested at a daily dose of 3 g for seven days. | [58] |
In vivo | The purpose of this research was to determine the metabolic effect of an OFI extract in a diet-induced obese mouse model. The extract was added to a high-fat diet and administered for 12 weeks. | The doses used (0.3 and 0.6%) prevented the C57BL/6 mice from presenting high values of LDL-Cho, HDL-Cho, tCho and increasing their body weight. An improvement in glucose tolerance and an increase in energy expenditure were registered. In addition, the extract stimulated insulin secretion in isolated pancreatic islets. The decrease in metabolic abnormalities was associated with a higher content of mRNA for glucose transporter 2 (GLUT2) and peroxisome proliferator-activated receptor gamma (PPARγ). | [59] |
In vivo | To determine the nutritional potential of whole O. ficus-indica seeds (OFIws) and its effect on food intake, Wistar rats received a treatment based on a diet supplemented with OFIws for nine weeks in which the efficiency of feed conversion, the protein efficiency index, and body weight were observed. | The results indicated a significant decrease in blood glucose concentration and body weight; as well as an increase in HDL-Cho and glycogen in the liver and skeletal muscle. Which suggests that OFIws is a healthy and useful food for obesity treatments. | [66] |
Systematic review | Today, hundreds of weight loss products are in the global dietary supplement market. However, their effectiveness has not been fully proven. Through an electronic search, the effectiveness of PPFs was analyzed using published data from randomized clinical trials. | Five studies which varied in the design and quality of the reports were included. The analysis revealed a significant reduction in body mass index, body fat percentage, and tCho. Adverse events included gastric intolerance and flu symptoms. It is recommended to increase the number of clinical trials to have more consistent data. | [67] |
Systematic review | A bibliographic compilation was focused on the aspects of ethnobotany, toxicity, pharmacology, state of conservation, trade and chemistry of the medicinal plants used in Mexico, Central America and the Caribbean for the empirical treatment of obesity. | A total of 139 species were recorded, including O. robusta (OR), OM, OS, OM, OJ and OFI. The conclusions were: (a) There are no clinical studies in obese subjects using the medicinal plants mentioned in this review, (b) There are no herbal products approved in Mexico for the treatment of obesity, and (c) The need for other pharmacological, phytochemical, and toxicological studies with medicinal flora to obtain new antiobesity agents of high importance. | [68] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Madrigal-Santillán, E.; Portillo-Reyes, J.; Madrigal-Bujaidar, E.; Sánchez-Gutiérrez, M.; Mercado-Gonzalez, P.E.; Izquierdo-Vega, J.A.; Vargas-Mendoza, N.; Álvarez-González, I.; Fregoso-Aguilar, T.; Delgado-Olivares, L.; et al. Opuntia genus in Human Health: A Comprehensive Summary on Its Pharmacological, Therapeutic and Preventive Properties. Part 1. Horticulturae 2022, 8, 88. https://doi.org/10.3390/horticulturae8020088
Madrigal-Santillán E, Portillo-Reyes J, Madrigal-Bujaidar E, Sánchez-Gutiérrez M, Mercado-Gonzalez PE, Izquierdo-Vega JA, Vargas-Mendoza N, Álvarez-González I, Fregoso-Aguilar T, Delgado-Olivares L, et al. Opuntia genus in Human Health: A Comprehensive Summary on Its Pharmacological, Therapeutic and Preventive Properties. Part 1. Horticulturae. 2022; 8(2):88. https://doi.org/10.3390/horticulturae8020088
Chicago/Turabian StyleMadrigal-Santillán, Eduardo, Jacqueline Portillo-Reyes, Eduardo Madrigal-Bujaidar, Manuel Sánchez-Gutiérrez, Paola E. Mercado-Gonzalez, Jeannett A. Izquierdo-Vega, Nancy Vargas-Mendoza, Isela Álvarez-González, Tomás Fregoso-Aguilar, Luis Delgado-Olivares, and et al. 2022. "Opuntia genus in Human Health: A Comprehensive Summary on Its Pharmacological, Therapeutic and Preventive Properties. Part 1" Horticulturae 8, no. 2: 88. https://doi.org/10.3390/horticulturae8020088
APA StyleMadrigal-Santillán, E., Portillo-Reyes, J., Madrigal-Bujaidar, E., Sánchez-Gutiérrez, M., Mercado-Gonzalez, P. E., Izquierdo-Vega, J. A., Vargas-Mendoza, N., Álvarez-González, I., Fregoso-Aguilar, T., Delgado-Olivares, L., Morales-González, Á., Anguiano-Robledo, L., & Morales-González, J. A. (2022). Opuntia genus in Human Health: A Comprehensive Summary on Its Pharmacological, Therapeutic and Preventive Properties. Part 1. Horticulturae, 8(2), 88. https://doi.org/10.3390/horticulturae8020088